Chen R, Ai L, Zhang J, Jiang D
Int J Nanomedicine. 2024; 19:11701-11718.
PMID: 39558915
PMC: 11571930.
DOI: 10.2147/IJN.S466363.
Kan C, Tan Z, Wang H, Wang W, Yang J, Zhang Y
Adv Sci (Weinh). 2024; 11(43):e2310282.
PMID: 39308190
PMC: 11578311.
DOI: 10.1002/advs.202310282.
Burdick L, DelVichio A, Hanson L, Griffith B, Bouchard K, Hunter J
Biomolecules. 2024; 14(2).
PMID: 38397414
PMC: 10886767.
DOI: 10.3390/biom14020177.
Gueguen J, Girard D, Rival B, Fernandez J, Goriot M, Banzet S
Commun Biol. 2023; 6(1):932.
PMID: 37700159
PMC: 10497574.
DOI: 10.1038/s42003-023-05316-w.
Zhao C, Inada Y, Sekiguchi K, Hino K, Nishio M, Yamada Y
Genes Dis. 2023; 10(3):731-734.
PMID: 37396524
PMC: 10308156.
DOI: 10.1016/j.gendis.2022.09.002.
A Rare Presentation of Myositis Ossificans in a Diabetic Individual.
Jogiya P, Hind J, Sidhu G, Suryawanshi S, Amara V, Ashwood N
J Orthop Case Rep. 2023; 12(10):50-53.
PMID: 36874884
PMC: 9983389.
DOI: 10.13107/jocr.2022.v12.i10.3362.
The role of miRNA and lncRNA in heterotopic ossification pathogenesis.
Pulik L, Mierzejewski B, Sibilska A, Grabowska I, Ciemerych M, Legosz P
Stem Cell Res Ther. 2022; 13(1):523.
PMID: 36522666
PMC: 9753082.
DOI: 10.1186/s13287-022-03213-3.
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery.
Yang Y, Kim J, Xie J, Chaugule S, Lin C, Ma H
Nat Commun. 2022; 13(1):6175.
PMID: 36258013
PMC: 9579182.
DOI: 10.1038/s41467-022-33956-9.
Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification.
Felix-Ilemhenbhio F, Pickering G, Kiss-Toth E, Wilkinson J
Int J Mol Sci. 2022; 23(13).
PMID: 35805978
PMC: 9266941.
DOI: 10.3390/ijms23136983.
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.
Yamamoto M, Stoessel S, Yamamoto S, Goldhamer D
J Bone Miner Res. 2022; 37(11):2077-2093.
PMID: 35637634
PMC: 9708949.
DOI: 10.1002/jbmr.4617.
Cancellous bone-like tissue replacement from calcinosis in patients with systemic sclerosis with multiple external root resorption.
Memida T, Matsuda S, Nakamoto T, Ouhara K, Kajiya M, Hirata S
Bone Rep. 2022; 16:101165.
PMID: 35059476
PMC: 8760497.
DOI: 10.1016/j.bonr.2021.101165.
Fibrodysplasia Ossificans Progressiva: What Have We Achieved and Where Are We Now? Follow-up to the 2015 Lorentz Workshop.
de Ruiter R, Smilde B, Pals G, Bravenboer N, Knaus P, Schoenmaker T
Front Endocrinol (Lausanne). 2021; 12:732728.
PMID: 34858325
PMC: 8631510.
DOI: 10.3389/fendo.2021.732728.
A Transgenic Rat for Noninvasive Assessment of Chondrogenesis .
Ferreira E, Gatrell L, Childress L, Wu H, Porter R
Cartilage. 2021; 13(2_suppl):1720S-1733S.
PMID: 34809478
PMC: 8804729.
DOI: 10.1177/19476035211057243.
Burn-induced heterotopic ossification from incidence to therapy: key signaling pathways underlying ectopic bone formation.
Hu X, Sun Z, Li F, Jiang C, Yan W, Sun Y
Cell Mol Biol Lett. 2021; 26(1):34.
PMID: 34315404
PMC: 8313878.
DOI: 10.1186/s11658-021-00277-6.
Inhibition of IL-17 prevents the progression of traumatic heterotopic ossification.
Tu B, Yu B, Wang W, Li J, Yuan F, Zhu J
J Cell Mol Med. 2021; 25(16):7709-7719.
PMID: 34189826
PMC: 8358870.
DOI: 10.1111/jcmm.16617.
Quercetin Attenuates Trauma-Induced Heterotopic Ossification by Tuning Immune Cell Infiltration and Related Inflammatory Insult.
Li J, Sun Z, Luo G, Wang S, Cui H, Yao Z
Front Immunol. 2021; 12:649285.
PMID: 34093537
PMC: 8173182.
DOI: 10.3389/fimmu.2021.649285.
New Strategies in Neurogenic Heterotopic Ossification.
Ampadiotaki M, Evangelopoulos D, Pallis D, Vlachos C, Vlamis J, Evangelopoulos M
Cureus. 2021; 13(4):e14709.
PMID: 34055549
PMC: 8158068.
DOI: 10.7759/cureus.14709.
Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men.
Cappato S, Gamberale R, Bocciardi R, Brunelli S
Biomedicines. 2020; 8(12).
PMID: 33327623
PMC: 7765130.
DOI: 10.3390/biomedicines8120611.
Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies.
Wong K, Mychasiuk R, OBrien T, Shultz S, McDonald S, Brady R
Bone Res. 2020; 8(1):42.
PMID: 33298867
PMC: 7725771.
DOI: 10.1038/s41413-020-00119-9.
Metformin attenuates trauma-induced heterotopic ossification via inhibition of Bone Morphogenetic Protein signalling.
Lin H, Shi F, Jiang S, Wang Y, Zou J, Ying Y
J Cell Mol Med. 2020; 24(24):14491-14501.
PMID: 33169942
PMC: 7754007.
DOI: 10.1111/jcmm.16076.